ASPIRE Common QCs - PUEV and SEV

Slides:



Advertisements
Similar presentations
1 MTN-003 Training Follow-up Visit Scheduling and Visit Coding SSP Sections and
Advertisements

Overview of Follow-up Visit Types and Visit Scheduling Training Binder Tab: Follow-up Visits.
ASPIRE Off-Site Visits. Rationale Why make an allowance for off-site visits in the protocol? Adherence & Retention Off-site visits Improving Clinic Flow.
HIV Counseling &Testing. Page 346 HIV and Risk Reduction (RR) Counseling Required at all scheduled visits Includes HIV Pre- and Post-test counseling.
ASPIRE TRAINING RANDOMIZATION & INITIAL DISPENSING Cindy Jacobson, PharmD (MTN) Jen Berthiaume/Missy Cianciola (SCHARP)
Reportable AEs – Report on AE Log CRF
G ENITAL B LEEDING ASPIRE SSP Section Updates 31 January 2014.
1 DataFax Overview and CRF Completion MTN 003 Training.
Data Collection Update SPECIAL DIABETES PROGRAM FOR INDIANS Diabetes Prevention Program: Year 4 Meeting 2 Jenn Russell.
Competitive Grant Program: Year 2 Meeting 3. SPECIAL DIABETES PROGRAM FOR INDIANS Competitive Grant Program: Year 2 Meeting 3 Jeanne M. Amos HH Data Coordinator.
Special Diabetes Program for Indians Competitive Grant Program SPECIAL DIABETES PROGRAM FOR INDIANS Competitive Grant Program Orientation for New Staff.
1 MTN 003 Data Management Considerations SSP Sections 14, 15 & 17.
ASPIRE TRAINING Study Product Considerations & Accountability for Non-Pharmacy Staff.
We will begin at 6pm-see you soon!. Psychiatric and Clinical Treatment at Open Sky Mark Braunstein, DO Psychiatrist.
Home screen of your online tracker system Updates or notes for your attention are placed at the top in red. This will also inform you of the document turnaround.
ACRIN 6698 Diffusion-weighted MRI Biomarkers for Assessment of Breast Cancer Response to Neoadjuvant Treatment: An I-SPY 2 Trial Substudy Presented by:
SSP Manual Update 31 January 2014 Version 1.3 Overview of changes which affect implementation.
Elements of Clinical Trial Quality Assurance Regulatory Coordinator –SCTR SUCCESS Center QA Monitor – NIDA Clinical Trials Network Stephanie Gentilin,
Overview of Enrollment Procedures. Training Materials for this session  All materials for this session can be found under the Enrollment tab of your.
MTN-027 Laboratory Related CRFs. Pharmacokinetics Specimens (PKS-1) - Enrollment, Day 28 Pharmacokinetics Specimens (PKD-1) - Days 1, 2, 3, 7, 14, 21,
SMART Study Closeout Washington ICC Meeting 03 June 2007.
Approve Documents (Requisitions) in Owl Link Updated May 3, 2012.
(Click to advance to next slide throughout this presentation) WASHINGTON STATE UNIVERSITY COLLEGE OF NURSING | GRADUATE PROGRAMS Year 1 Semester 3 Preparation.
Participant Retention Plans MTN-003 Study-Specific Training.
MTN-027 Clinical Management CRFs. CRFs for Clinical Management Physical Exam Pelvic Exam Diagrams Pelvic Exam Pelvic Exam Ring Assessment Clinical Product.
Investigator’s Meeting
CourseWhere Guide for Instructors. To View, Print and Update Attendance and Grades Log on to CourseWhere using your ID and password Link to CourseWhere:
How to run APR and APR detail For those who has ART license.
Researcher training for ACAP © Created by Isaac P. E. Mailleue Research Integrity Coordinator University of North Carolina at Greensboro September 2013.
Vendor’s Malt Manufacturing Return. Log in with the user id and password provided through the EDS registration process and click on the Login button.
Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-term Effectiveness (ADAPTABLE) Trial 05 October 2015 Update.
Module Three: Identifying your Patient in SIS. Introduction – Search for 1 st T Specimen The Search for 1 st T Specimen screen is used to access your.
Protocol Deviations. MTN protocol deviation policy  MTN has recently revised their policy on PDs- this policy will be made available on the MTN website.
MTN-028 Laboratory Related CRFs. Pharmacokinetics Specimens (PKS-1) - Enrollment, Day 28 Pharmacokinetics Specimens (PKD-1) - Days 1, 2, 3, 7, 14, 21,
Social Harms Reporting in ASPIRE Training Binder p.275.
Follow-up Case Report Forms SCHARP. Follow-up Visit CRFs Monthly Visits Date of Visit Follow-up Visit Summary Ring Adherence (Y/N) prompt Laboratory Results.
Participant Tracking Database (PTD) Overview Access database is an optional tool for tracking participant visit scheduling and visits throughout HOPE.
MTN-025/HOPE Decliner Population Procedures. Who are the Decliner Population? Former ASPIRE participants who decline or express no interest in joining.
Søren Marker Jensen, MD, coordinating investigator
Planning for HOPE PUEVs and Study Exit Visits
Overview of Visit Scheduling and Types of Follow-up Visits SCHARP
HOPE SSP Updates May 2017.
Protocol Deviations.
Management of Pregnancies
Data Collection Interview
30 April 2015 Updated 29 December 2015
MTN-025 Data Communiqué #1 CRF Updates.
HOW TO CONSENT A PATIENT?
Protocol References Section Title 6.2 Entry Visit 5.1
HMIS Updates New Data Quality Framework in HMIS
HOPE STUDY PRODUCT TRAINING PHASE 2
Protocol References Section Title 6.2 Entry Visit 5.1
360o Feedback Report Post-Training After-Session Actions
MTN-037 Training Julie Ngo SCHARP April 12, 2018.
Ariana Katz WGHI/RTI International San Francisco, CA
Social Harms Reporting in MTN-017
MTN-020 Common QCs and Form Completion Questions
Administering Behavioral CRFs
April 4-5, 2018 The Four Seasons Baltimore
Data Management in Support of A Clinical Event Committee (CEC)
ACASI Questionnaire Schedule - Oral
Reporter Training for High School RIOTM
UPDATE: DRSi MERRecorder (ALERT MODULE)
HOPE STUDY PRODUCT TRAINING
E-CRF Overview Oracle® Clinical Remote Data Capture Training (Version 4.6 HTML) e-CRF Completion John McDonach Manager CDM, PPD.
Problem Statement and Significance
Module 4 Part 3 Operationalizing the Measures
Interim Assessments View Only for Teachers
Now Buy Best External Door Hardware from Doorhardware
Reporter Training for High School RIOTM
Presentation transcript:

ASPIRE Common QCs - PUEV and SEV April 30, 2015

What are most common QCs at the PUEV and SEVs?

Visit Summary (VS-1) CRF Item 4a: If the PUEV or SEV visit is not an interim visit, remember to follow the skip pattern in Item 4a. If the study visit is not an interim visit and item 5 is completed, a QC will be applied. To correct this QC, line through the response in item 5, initial, date, and refax to SCHARP. JMB 4/30/15

Visit Summary (VS-1) CRF Item 4a: Please mark item 4a as “PUEV” for participants who are exiting from ASPIRE at the PUEV. The “scheduled termination” box in item 4a should only be marked if the participant is completing her scheduled SEV approximately four weeks after her PUEV.

Concomitant Medications log CRF Date Stopped: If a medication is ongoing at end of study, mark “Continuing at end of study”. If this checkbox is marked, a date stopped should not be provided. √

Follow-up ACASI Tracking (FAT-1) CRF Items 2 and 2a: If Item 2 is marked ‘yes’ to indicate that there was an issue in administering the PUEV/Discontinuers ACASI questionnaire, describe the issue in as much detail as possible in item 2a. The Month 3 questionnaire was completed in error at this participant’s PUEV instead of the required PUEV/Discontinuers questionnaire.

AE log CRF Status/Outcome: If an AE is continuing at the end of a participant’s study participation, update Item 6 by lining through the ‘continuing’ box, marking ‘continuing at end of study participation’ and initial, date, and refax to SCHARP.

End of Study Inventory (ESI-1) CRF Item 4: If no pages were submitted for any of the forms listed in items 4a-4g, mark ‘no pages submitted’ for that log form If ‘00’ is indicated as the highest page number, a QC will be applied. JMB 30apr15

PUEV Laboratory Results (PLR-1) CRF Item 1: If a Pap Smear is performed on the second day of a split PUEV, indicate the date that the assessment was performed using the “alternate collection date” field.

Social Influences Assessment (SOC-1) CRF Item 2: If ‘99’ or ‘05’ is indicated as the relationship for persons 1-5, specify this relationship to the study participant in English on the line provided. Sister JMB 30apr15

STI Test Results (STI-1) CRF If an item is initially marked ‘not done/not collected’ and later completed with the visit window for the visit, complete the alternate collection date for that item and remember to line through the original response of ‘not done/not collected’ and initial and date this update. Jmb 30apr15

Product Hold/ Discontinuation Log CRF Item 4: Remember to update Item 4 on a PH log CRF for any clinical product holds that are ongoing at a participant’s scheduled PUEV.

Questions? Please contact Jen Berthiaume (jberthia@scharp.org) with any questions you have about this slide presentation.